logo-large
  • Browse Categories

Publications by authors named "Els Festjens"

Claim this Profile
D
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling.
Anna Hultberg, Virginia Morello, Leander Huyghe, Natalie De Jonge, Christophe Blanchetot, Els Festjens

Cancer Res· August 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four individually druggable MET hotspots mediate HGF-driven tumor progression.
Cristina Basilico, Anna Hultberg, Christophe Blanchetot, Natalie de Jonge, Els Festjens

J Clin Invest· July 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
Karim El Bakkouri, Francis Descamps, Marina De Filette, Anouk Smet, Els Festjens

J Immunol· January 2011


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
Dubravka Grdic Eliasson, Karim El Bakkouri, Karin Schön, Anna Ramne, Els Festjens

Vaccine· February 2008


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: